Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario

Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario

Bibliographic Details
Main Authors:	Alexandra M. Franklyn, Joseph K. Eibl, Graham Gauthier, David Pellegrini, Nancy E. Lightfoot, David C. Marsh
Format:	Article
Language:	English
Published:	BMC 2017-03-01
Series:	Harm Reduction Journal
Online Access:	http://link.springer.com/article/10.1186/s12954-017-0140-7

Similar Items

The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada.
by: Alexandra M Franklyn, et al.
Published: (2017-01-01)

Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada
by: Kristen A. Morin, et al.
Published: (2019-06-01)

A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada.
by: Kristen A Morin, et al.
Published: (2020-01-01)

The opioid crisis: past, present and future policy climate in Ontario, Canada
by: Kristen A. Morin, et al.
Published: (2017-11-01)

A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data
by: Kristen A. Morin, et al.
Published: (2020-07-01)

Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada.
by: Kristen A Morin, et al.
Published: (2020-01-01)

Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
by: Kristen A. Morin, et al.
Published: (2021-12-01)

Canadian Addiction Treatment Centre (CATC) opioid agonist treatment cohort in Ontario, Canada
by: David Marsh, et al.
Published: (2024-02-01)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
by: Chrianna Bharat, et al.
Published: (2022-08-01)

Association of prescribed oral stimulants on cocaine use among patients enrolled in opioid agonist treatment: A retrospective longitudinal cohort study
by: Mark Tatangelo, et al.
Published: (2022-12-01)

Comparison of Five Benzodiazepine-Receptor Agonists on Buprenorphine-Induced µ-Opioid Receptor Regulation
by: Géraldine Poisnel, et al.
Published: (2009-01-01)

Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care framework
by: Farah Tahsin, et al.
Published: (2022-04-01)

Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort study
by: David Marsh, et al.
Published: (2022-10-01)

Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey.
by: Fiona G Kouyoumdjian, et al.
Published: (2018-01-01)

Erratum: Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study
by: Frontiers Production Office
Published: (2022-12-01)

Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study
by: Maximilian Meyer, et al.
Published: (2023-07-01)

A study protocol for a quasi-experimental community trial evaluating the integration of indigenous healing practices and a harm reduction approach with principles of seeking safety in an indigenous residential treatment program in Northern Ontario
by: T. N. Marsh, et al.
Published: (2021-03-01)

Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses
by: Zin CS, et al.
Published: (2017-01-01)

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder
by: Mark K. Greenwald, et al.
Published: (2023-01-01)

Community trial evaluating the integration of Indigenous healing practices and a harm reduction approach with principles of seeking safety in an Indigenous residential treatment program in northern Ontario
by: K. A. Morin, et al.
Published: (2022-08-01)

Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?
by: Lydia J. Finney
Published: (2019-06-01)

Implementation and evaluation of a two-eyed seeing approach using traditional healing and seeking safety in an indigenous residential treatment program in Northern Ontario
by: T.N. Marsh, et al.
Published: (2022-12-01)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
by: Jørn Henrik Vold, et al.
Published: (2020-04-01)

Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
by: Cayley Russell, et al.
Published: (2022-12-01)

Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
by: Cayley Russell, et al.
Published: (2022-03-01)

Benzodiazepine Use in Opioid Maintenance Treatment Programme: Risks and Clinical Outcomes
by: Catarina Oliveira, et al.
Published: (2021-03-01)

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
by: Marchand Kirsten, et al.
Published: (2012-01-01)

Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review
by: Yanning Wang, et al.
Published: (2023-02-01)

Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993–2014
by: Matthew E. Hirschtritt, et al.
Published: (2018-03-01)

Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients
by: Soodaba Mir, et al.
Published: (2020-08-01)

Screening and Confirmation of Opioids, Amphetamines and Benzodiazepines in Wastewater by High-Resolution Mass Spectrometry
by: YUAN Shuai, et al.
Published: (2021-11-01)

Relation between preoperative benzodiazepines and opioids on outcomes after total joint arthroplasty
by: Lisa V. Doan, et al.
Published: (2021-05-01)

Anticonvulsant Effects of Aerial Parts of Extract in Mice: Involvement of Benzodiazepine and Opioid Receptors
by: Amir Rashidian PharmD, PhD, et al.
Published: (2017-10-01)

Anticonvulsant activity of Dorema ammoniacum gum: evidence for the involvement of benzodiazepines and opioid receptors
by: Manijeh Motevalian, et al.
Published: (2017-01-01)

Linking the Narcotics Monitoring System Database to Quantify the Contribution of Prescribed and Non-Prescribed Opioids to Opioid Overdoses in Ontario, Canada
by: Diana Martins, et al.
Published: (2018-08-01)

New opioid use and risk of opioid-related adverse events among adults with intellectual and developmental disabilities in Ontario, Canada
by: Qi Guan, et al.
Published: (2022-11-01)

The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
by: Tricklebank, MD, et al.
Published: (1990)

Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study
by: Kristien Coteur, et al.
Published: (2022-09-01)

A unified model of the GABA(A) receptor comprising agonist and benzodiazepine binding sites.
by: Rikke Bergmann, et al.
Published: (2013-01-01)

Therapeutic Potential of Kappa Opioid Agonists
by: Tyler C. Beck, et al.
Published: (2019-06-01)